nach oben

Erschienen in:

2018 | OriginalPaper | Buchkapitel

7. Liquid Metal as Vascular Embolic Agent in Tumor Therapy

verfasst von : Jing Liu, Liting Yi

Erschienen in: Liquid Metal Biomaterials

Verlag: Springer Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

This chapter illustrates a new conceptual vascular embolization therapy enabled by the liquid metal materials. Several typical experiments on in vivo animal vasculatures were presented to illustrate the evidences of the method in destroying the targeted tissues. Through appropriate administration, the liquid metal embolization is able to destruct the target regions which might starve the tumors to death through a relatively easy way. Meanwhile, theoretical valuation regarding the tumor growth with zero, partial or complete filling of the metal agent inside the vessels were also given to evaluate the liquid metal starvation therapy effects.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Liquid Metal Image Contrast Agent in Angiography

Nächstes Kapitel Liquid Metal Enabled Injectable Biomedical Electronics

Wang Q, Yu Y, Liu J (2014) Delivery of liquid metal to the target vessels as vascular embolic agent to starve diseased tissues or tumors to death. arXiv: 1408.0989

Esther W, Michael S, Yosef Y (2010) Roles for growth factors in cancer progression. Physiology 25(2):85–101CrossRef

Zhimin L, Guo J, Peter B, Tony H (2001) Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21(12):4016–4031CrossRef

Wells A (2000) Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78:31–101CrossRef

Folkman J (1974) Tumor angiogenesis factor. Can Res 34(8):2109–2113

Jain RK (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9(3):253–266CrossRef

Eichhorn ME, Strieth S, Dellian M (2004) Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives. Drug Resist Updates Rev Commentaries Antimicrob Anticancer Chemother 7(2):125–138

Thorpe PE (2004) Vascular targeting agents as cancer therapeutics. Clin Cancer Res (An Official Journal of the American Association for Cancer Research) 10(2):415–427CrossRef

Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82(1):4–7CrossRef

10.

Kerbel RS (2000) Tumor angiogenesis: past, present and the near future. Carcinogenesis 21(3):505–515CrossRef

11.

John A, Tuszynski G (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7(1):14–23CrossRef

12.

Kim KJ, Li B, Winer J, Armanini M, Gillett N, Philips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362(6423):841–844CrossRef

13.

O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277–285CrossRef

14.

Feldman AL, Libutti SK (2000) Progress in antiangiogenic gene therapy of cancer. Cancer 89(6):1181–1194CrossRef

15.

Quesada AR, Medina MA, Alba E (2007) Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. BioEssays 29(11):1159–1168CrossRef

16.

Philip ET, David JC, David CB (2003) The first international conference on vascular targeting: meeting overview. Can Res 63(5):1144–1147

17.

Denekamp J (1999) The tumour microcirculation as a target in cancer therapy: a clearer perspective. Eur J Clin Invest 29(9):733–736CrossRef

18.

Hori K, Saito S, Kubota K (2002) A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs. Br J Cancer 86(10):1604–1614CrossRef

19.

Lovet JM, Bruix J (2003) Systematic review of randomized trials for unrespectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37(2):429–442CrossRef

20.

Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9(2):193–200CrossRef

21.

Yu H, Zhu G, Xu R et al (2011) Arterial embolization hyperthermia using As₂O₃ nanoparticles in VX2 carcinoma-induced liver tumors. PLoS ONE 6(3):e17926CrossRef

22.

Chen X, Lv H, Ye M, Wang S, Ni E, Zeng F, Cap C, Luo F, Yan J (2012) Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting. Int J Pharm 426(1–2):248–255CrossRef

23.

Teng MM, Chang CY, Chiang JH, Lirng JF, Luo CB, Chen SS, Chang FC, Guo WY (2000) Double-balloon technique for embolization of carotid cavernous fistulas. Am J Neuroradiol 21(9):1753–1756

24.

Joseph LB (2005) Cardiovascular bubble dynamics. Crit Rev Biomed Eng 33(4):299–346CrossRef

25.

Claus MM, Erik SS (2000) Gas embolism. N Engl J Med 342(7):476–482CrossRef

26.

Wang Q, Yu Y, Pan K, Liu J (2014) Liquid metal angiography for mega contrast X-ray visualization of vascular network in reconstructing in-vitro organ anatomy. IEEE Trans Biomed Eng 61(7):2161–2166CrossRef

27.

Anderson ARA (2005) A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 22(2):163–186CrossRef

28.

Ma KQ, Liu J (2007) Nano liquid-metal fluid as ultimate coolant. Phys Lett A 361(3):252–256CrossRef

Titel: Liquid Metal as Vascular Embolic Agent in Tumor Therapy
verfasst von: Jing Liu
Liting Yi
Verlag: Springer Singapore
Buch: Liquid Metal Biomaterials
Print ISBN: 978-981-10-5606-2

Electronic ISBN: 978-981-10-5607-9

Copyright-Jahr: 2018
DOI: https://doi.org/10.1007/978-981-10-5607-9_7

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht